Patents by Inventor Sean Deacon

Sean Deacon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF ACTIVATED CDC42-ASSOCIATED KINASE 1
    Publication number: 20140163028
    Abstract: Compounds, compositions, and methods for specific inhibition of activated cdc42-associated kinase 1 (Ack1) are provided.
    Type: Application
    Filed: January 24, 2014
    Publication date: June 12, 2014
    Applicant: Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
    Inventors: Jeffrey R. Peterson, Haiching Ma, Sean Deacon
  • Inhibition of activated cdc42-associated kinase 1
    Patent number: 8658655
    Abstract: Compounds, compositions, and methods for specific inhibition of activated cdc42-associated kinase 1 (Ack1) are provided.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: February 25, 2014
    Assignees: Fox Chase Cancer Center, Reaction Biology Corporation
    Inventors: Jeffrey R. Peterson, Haiching Ma, Sean Deacon
  • INHIBITION OF ACTIVATED CDC42-ASSOCIATED KINASE 1
    Publication number: 20120245173
    Abstract: Compounds, compositions, and methods for specific inhibition of activated cdc42-associated kinase 1 (Ack1) are provided.
    Type: Application
    Filed: March 26, 2012
    Publication date: September 27, 2012
    Applicants: Reaction Biology Corporation, Fox Chase Cancer Center
    Inventors: Jeffrey R. Peterson, Haiching Ma, Sean Deacon